BACKGROUND: We investigated the role of tandem pore potassium ion channel (K2P) TRESK in neurobehavioral function and volatile anesthetic sensitivity in genetically modified mice. METHODS: Exon III of the mouse TRESK gene locus was deleted by homologous recombination using a targeting vector. The genotype of bred mice (wild type, knockout, or heterozygote) was determined using polymerase chain reaction. Morphologic and behavioral evaluations of TRESK knockout mice were compared with wild-type littermates. Sensitivity of bred mice to isoflurane, halothane, sevoflurane, and desflurane were studied by determining the minimum alveolar concentration preventing movement to tail clamping in 50% of each genotype. RESULTS: With the exception of decreased number of inactive periods and increased thermal pain sensitivity (20% decrease in latency with hot plate test), TRESK knockout mice had healthy development and behavior. TRESK knockout mice showed a statistically significant 8% increase in isoflurane minimum alveolar concentration compared with wild-type littermates. Sensitivity to other volatile anesthetics was not significantly different. Spontaneous mortality of TRESK knockout mice after initial anesthesia testing was nearly threefold higher than that of wild-type littermates. CONCLUSIONS: TRESK alone is not critical for baseline central nervous system function but may contribute to the action of volatile anesthetics. The inhomogeneous change in anesthetic sensitivity corroborates findings in other K2P knockout mice and supports the theory that the mechanism of volatile anesthetic action involves multiple targets. Although it was not shown in this study, a compensatory effect by other K2P channels may also contribute to these observations.
BACKGROUND: We investigated the role of tandem pore potassium ion channel (K2P) TRESK in neurobehavioral function and volatile anesthetic sensitivity in genetically modified mice. METHODS: Exon III of the mouseTRESK gene locus was deleted by homologous recombination using a targeting vector. The genotype of bred mice (wild type, knockout, or heterozygote) was determined using polymerase chain reaction. Morphologic and behavioral evaluations of TRESK knockout mice were compared with wild-type littermates. Sensitivity of bred mice to isoflurane, halothane, sevoflurane, and desflurane were studied by determining the minimum alveolar concentration preventing movement to tail clamping in 50% of each genotype. RESULTS: With the exception of decreased number of inactive periods and increased thermal pain sensitivity (20% decrease in latency with hot plate test), TRESK knockout mice had healthy development and behavior. TRESK knockout mice showed a statistically significant 8% increase in isoflurane minimum alveolar concentration compared with wild-type littermates. Sensitivity to other volatile anesthetics was not significantly different. Spontaneous mortality of TRESK knockout mice after initial anesthesia testing was nearly threefold higher than that of wild-type littermates. CONCLUSIONS:TRESK alone is not critical for baseline central nervous system function but may contribute to the action of volatile anesthetics. The inhomogeneous change in anesthetic sensitivity corroborates findings in other K2P knockout mice and supports the theory that the mechanism of volatile anesthetic action involves multiple targets. Although it was not shown in this study, a compensatory effect by other K2P channels may also contribute to these observations.
Authors: David Mu; Liyun Chen; Xiping Zhang; Lei-Hoon See; Christina M Koch; Clifford Yen; James Jiayuan Tong; Lori Spiegel; Ken C Q Nguyen; Allyson Servoss; Yue Peng; Lin Pei; Jeffrey R Marks; Scott Lowe; Timothy Hoey; Lily Yeh Jan; W Richard McCombie; Michael H Wigler; Scott Powers Journal: Cancer Cell Date: 2003-03 Impact factor: 31.743
Authors: C Heurteaux; N Guy; C Laigle; N Blondeau; F Duprat; M Mazzuca; L Lang-Lazdunski; C Widmann; M Zanzouri; G Romey; M Lazdunski Journal: EMBO J Date: 2004-06-03 Impact factor: 11.598
Authors: Herve Barriere; Radia Belfodil; Isabelle Rubera; Michel Tauc; Florian Lesage; Chantal Poujeol; Nicolas Guy; Jacques Barhanin; Philippe Poujeol Journal: J Gen Physiol Date: 2003-07-14 Impact factor: 4.086
Authors: Dinesh Pal; Meredith E Walton; William J Lipinski; Lauren G Koch; Ralph Lydic; Steve L Britton; George A Mashour Journal: Anesth Analg Date: 2011-12-13 Impact factor: 5.108
Authors: Ann-Kathrin Rahm; Jakob Gierten; Jana Kisselbach; Ingo Staudacher; Kathrin Staudacher; Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas Journal: Br J Pharmacol Date: 2012-05 Impact factor: 8.739
Authors: Ann-Kathrin Rahm; Felix Wiedmann; Jakob Gierten; Constanze Schmidt; Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2013-12-06 Impact factor: 3.000